Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Amortizatization of Intangibles of $573000.0 in Q1 2026, up 49.61% quarter-over-quarter from $383000.0 in Q4 2025, and up 26.49% on a YoY basis from $453000.0 in Q1 2025.
Tg Therapeutics (TGTX) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Tg Therapeutics' Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $573000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 26.49% year-over-year to $573000.0; the TTM figure through Mar 2026 stood at $3.9 million (up 472.18% YoY), while the FY2025 annual figure was $3.8 million, up 99.37% from the prior year.
- Amortizatization of Intangibles was $573000.0 for Q1 2026 at Tg Therapeutics, up from $383000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.2 million in Q2 2025 to a low of -$2.1 million in Q3 2024.
- Historically, Amortizatization of Intangibles has averaged $503235.3 across 5 years, with a median of $383000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles surged 1408.7% in 2023, then slumped 1053.0% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $172000.0 in 2022, then soared by 631.98% to $1.3 million in 2023, then plunged by 60.44% to $498000.0 in 2024, then decreased by 23.09% to $383000.0 in 2025, then jumped by 49.61% to $573000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $573000.0 (Q1 2026), $383000.0 (Q4 2025), and $786000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 573,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 573,000.00 |
| Mar 31, 2026 | 573,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 786,000.00 |
| Sep 30, 2025 | 786,000.00 |
| Jun 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 453,000.00 |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 498,000.00 |
| Dec 31, 2024 | 498,000.00 |
| Sep 30, 2024 | -2.07 Mn |
| Sep 30, 2024 | -2.07 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |